Science Explorer Back to mapMap
Discussion
Company · Pudong · China

GenomiCare (China)

genomicarebio.comROR OpenAlex
Research works
25
▼ 61% vs 2018-21
Citations
259
10.5 per fractional work
Top-10% rate
8.6%
all institutions 10.0%
Open access
54%
world 40%
International
13%
world 18%
GenomiCare (China)

Not ranked overall: GenomiCare (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does GenomiCare (China) work in?

In all years, 65% of research at GenomiCare (China) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (63%), Biochemistry, Genetics and Molecular Biology (30%), Health Professions (3%). It does 2.2× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 65.4% of its workMedicine: 15 fractional works · 62.6% of its workOncology: 5 fractional works · 20.4% of its workPulmonary and Respiratory Medicine: 4 fractional works · 15.2% of its workPathology and Forensic Medicine: 1 fractional works · 5.2% of its workGenetics: 1 fractional works · 4.9% of its workSurgery: 1 fractional works · 4.2% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.2% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.3% of its workNeurology: 0 fractional works · 1.3% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.0% of its workPhysiology: 0 fractional works · 0.9% of its workPsychiatry and Mental health: 0 fractional works · 0.9% of its workRheumatology: 0 fractional works · 0.9% of its workEpidemiology: 0 fractional works · 0.7% of its workOtorhinolaryngology: 0 fractional works · 0.7% of its workHealth Informatics: 0 fractional works · 0.4% of its workHematology: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workHealth Professions: 1 fractional works · 2.7% of its workGeneral Health Professions: 1 fractional works · 2.7% of its workLife Sciences: 8 fractional works · 32.8% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 29.9% of its workCancer Research: 5 fractional works · 19.1% of its workMolecular Biology: 2 fractional works · 6.8% of its workGenetics: 1 fractional works · 3.7% of its workCell Biology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 0 fractional works · 1.5% of its workImmunology: 0 fractional works · 1.5% of its workAgricultural and Biological Sciences: 0 fractional works · 0.7% of its workPlant Science: 0 fractional works · 0.7% of its workNeuroscience: 0 fractional works · 0.6% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workNeurology: 0 fractional works · 0.3% of its workPhysical Sciences: 0 fractional works · 1.8% of its workEnvironmental Science: 0 fractional works · 1.3% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 1.3% of its workComputer Science: 0 fractional works · 0.4% of its workArtificial Intelligence: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 0.1% of its workBusiness, Management and Accounting: 0 fractional works · 0.1% of its workALL ITS WORKGenomiCare(China)25fractional works, all years
Life Sciences33%Physical Sciences2%Health Sciences65%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 9 fields, with their numbers
    1. Medicine1562.6%
    2. Health Professions12.7%
    1. Biochemistry, Genetics and Molecular Biology729.9%
    2. Immunology and Microbiology01.5%
    3. Agricultural and Biological Sciences00.7%
    4. Neuroscience00.6%
    1. Environmental Science01.3%
    2. Computer Science00.4%
    1. Business, Management and Accounting00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.00× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 3.64× its world share, 0 worksImmunology and Micro…Neuroscience: 0.54× its world share, 0 worksNeuroscienceComputer Science: 0.19× its world share, 0 worksComputer ScienceEnvironmental Science: 0.88× its world share, 0 worksEnvironmental ScienceHealth Professions: 3.33× its world share, 1 worksHealth ProfessionsMedicine: 3.08× its world share, 4 worksMedicineBusiness, Management and Accounting: 0.10× its world share, 0 worksBusiness, Management…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.0×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology4.00×2 works
  2. Immunology and Microbiology3.64×0 works
  3. Health Professions3.33×1 works
  4. Medicine3.08×4 works
  5. Environmental Science0.88×0 works
  6. Neuroscience0.54×0 works
  7. Computer Science0.19×0 works
  8. Business, Management and Accounting0.10×0 works

Who are the top researchers at GenomiCare (China)?

Ranked on the quality score, Jinwang Wei, Guan Wang and Wending Sun lead among researchers whose main affiliation is GenomiCare (China).

  1. 1 Jinwang Wei China · #944,977 worldwide 1.1k citations · 49 works
  2. 2 Guan Wang China · #2,113,858 worldwide 567 citations · 38 works
  3. 3 Wending Sun China · #2,381,538 worldwide 487 citations · 23 works
  4. 4 Chun Dai China · #2,468,438 worldwide 837 citations · 102 works
  5. 5 Shengzhou Wang China · #3,530,703 worldwide 181 citations · 29 works
All ranked researchers at GenomiCare (China)

What are the most cited papers from GenomiCare (China)?

The most cited paper from GenomiCare (China) is "Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling" (Xinya Gao, Xin Xia, Fanying Li et al., 2021), with 436 citations. Next come "Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer" (65) and "Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade" (50).

Most cited papers
#PaperReleasedCitations
1 Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling Xinya Gao, Xin Xia, Fanying Li et al. · Nature Cell Biology Mar 2021 436
2 Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer Yuan‐Sheng Zang, Chun Dai, Xiaoman Xu et al. · Cancer Medicine Open access 4 Jul 2019 65
3 Two cases of intrahepatic cholangiocellular carcinoma with high insertion-deletion ratios that achieved a complete response following chemotherapy combined with PD-1 blockade Minghao Sui, Yu Li, Hongguang Wang et al. · Journal for ImmunoTherapy of Cancer Open access 7 May 2019 50
4 Clinical and Molecular Characteristics of Thalamic Gliomas: Retrospective Report of 26 Cases Yikui Liu, Yi Zhang, Wei Hua et al. · World Neurosurgery 16 Mar 2019 46
5 Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors Jiaping Li, Wei Jiang, Jinwang Wei et al. · Journal of Translational Medicine Open access Aug 2020 40
All 51 most cited papers, with filters and sorting

Which keywords describe research at GenomiCare (China)?

By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cell-Free DNA, Cancer Genomics, Mutational Signatures, Chemotherapy, Tumor Microenvironment, Precision Medicine and Immune Checkpoint Blockade.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Targeted Therapy6▲ 106×3 topics
  2. Cell-Free DNA4▲ 202×2 topics
  3. Cancer Genomics4▲ 304×1 topic
  4. Mutational Signatures4▲ 304×1 topic
  5. Chemotherapy4▲ 21×11 topics
  6. Tumor Microenvironment3▲ 33×4 topics
  7. Precision Medicine2▲ 27×3 topics
  8. Cancer2▲ 5.4×8 topics
  9. Immune Checkpoint Blockade2▲ 141×1 topic
  10. PD-1 and PD-L12▲ 141×1 topic
  11. Cetuximab2▲ 88×2 topics
  12. Clinical Trials2▲ 11×3 topics
  13. Immunotherapy2▲ 11×5 topics
  14. Radiotherapy2▲ 18×4 topics
  15. Fluorouracil2▲ 197×1 topic
  16. Genomic Profiling2▲ 65×2 topics
  17. KRAS Mutations2▲ 197×1 topic
  18. Treatment Guidelines2▲ 29×2 topics
  19. ALK Inhibitors1▲ 104×1 topic
  20. EGFR Mutations1▲ 104×1 topic
  21. Prognostic Factors1▲ 12×6 topics
  22. Glioblastoma1▲ 82×1 topic
  23. Molecular Characterization1▲ 27×3 topics
  24. Temozolomide1▲ 82×1 topic
  25. Obesity1▲ 5.8×3 topics
  26. Mental Health1▲ 3.6×2 topics

Which research topics does GenomiCare (China) publish most on?

By volume in 2022-now: Health and Lifestyle Studies, Ferroptosis and cancer prognosis, Cancer Immunotherapy and Biomarkers and Cancer Genomics and Diagnostics.

Health and Lifestyle Stu…1Health and Lifestyle Studies: 1 fractional worksFerroptosis and cancer p…0Ferroptosis and cancer prognosis: 0 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksCancer Genomics and Diag…0Cancer Genomics and Diagnostics: 0 fractional worksGlioma Diagnosis and Treatment: 0 fractional worksColorectal Cancer Treatments and Studies: 0 fractional worksCancer Risks and Factors0Cancer Risks and Factors: 0 fractional worksAging, Health, and Disability: 0 fractional worksPublic Health and Environmental Issues: 0 fractional worksGallbladder and Bile Duc…0Gallbladder and Bile Duct Disorders: 0 fractional works
General Health ProfessionsPulmonary and Respiratory MedicineOncologyCancer Research3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health and Lifestyle Studies General Health Professions 1 works
  2. 2 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 Cancer Genomics and Diagnostics Cancer Research 0 works
  5. 5 Glioma Diagnosis and Treatment Genetics 0 works
  6. 6 Colorectal Cancer Treatments and Studies Oncology 0 works
  7. 7 Cancer Risks and Factors Oncology 0 works
  8. 8 Aging, Health, and Disability Public Health, Environmental and Occupational Health 0 works
  9. 9 Public Health and Environmental Issues Health, Toxicology and Mutagenesis 0 works
  10. 10 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.0%not open46.0%

World: 40% of research is openly available.

with international co-authors12.7%domestic only87.3%

World: 18% is written across borders.

How has GenomiCare (China)'s research output changed?

Output in 2022-2025 was 61% lower than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is GenomiCare (China) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.000050%0.00010%GenomiCare (China)0.000012% in 20252020

Fractional works of GenomiCare (China) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Pudong

All research institutions in Pudong

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about GenomiCare (China). Posts are plain text and can be reported.